LifeSci Acquisition II (LSAQ): Price and Financial Metrics
LSAQ Price/Volume Stats
| Current price | $9.01 | 52-week high | $12.68 |
| Prev. close | $9.25 | 52-week low | $8.42 |
| Day low | $8.42 | Volume | 41,600 |
| Day high | $9.02 | Avg. volume | 53,514 |
| 50-day MA | $9.92 | Dividend yield | N/A |
| 200-day MA | $10.32 | Market Cap | 90.20M |
LSAQ Stock Price Chart Interactive Chart >
LifeSci Acquisition II (LSAQ) Company Bio
LifeSci Acquisition II Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses for its initial business. The company was founded on December 18, 2019 and is headquartered in New York.
Latest LSAQ News From Around the Web
Below are the latest news stories about Lifesci Acquisition II Corp that investors may wish to consider to help them evaluate LSAQ as an investment opportunity.
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of LifeSci Acquisition II Corp. MergerWILMINGTON, Del., May 12, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating LifeSci Acquisition II Corp. (“LifeSci”) (NASDAQ GS: LSAQ) regarding possible breaches of fiduciary duties and other violations of law related to LifeSci’s agreement to merge with Science 37, Inc. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-lifesci-acquisition-ii-corp. You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected]. Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide. Attorne... |
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of LifeSci Acquisition II Corp. - LSAQJuan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating LifeSci Acquisition II Corp. ("LSAQ" or the "Company") (LSAQ) relating to its proposed merger with Science 37, Inc. Under the terms of the agreement, LSAQ will acquire Science 37 through a reverse merger, with Science 37 emerging as a publicly traded company. |
Moore Kuehn Encourages MNR, LOKB, LSAQ and MFNC Investors to Contact Law FirmNEW YORK, May 11, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: Monmouth Real Estate Investment Corporation (NYSE: MNR) Monmouth has agreed to merge with Equity Commonwealth. Under the proposed transaction, Monmouth shareholders will receive $19.58 in cash per share. Live Oak Acquisition Corp. II (NYSE: LOKB) Live Oak II has agreed to merge with Navitas Semiconductor. Under the proposed transaction, Live Oak II shareholders will only own 18.1% of the com... |
LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public OfferingNEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company targeting the biopharma sector, announced today that it priced its initial public offering of 7,500,000 shares at $10.00 per share. The shares will begin trading today on the NASDAQ Capital Market (“NASDAQ”) under the symbol “LSAQ.” LifeSci Capital LLC acted as lead book-running manager and Ladenburg Thalmann & Co. Inc. acted as joint book-running manager for the offering (the “Underwriters”). The underwriters have been granted a 45-day option to purchase up to an additional 1,125,000 shares offered by the Company to cover over-allotments, if any.The offering is expected to close on or about November 24, 2020, subject to customary closing conditions.A registration statement re... |
LSAQ Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -16.42% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...